Safety of Intravenous Methamphetamine in Patients Taking Mirtazapine
Mirtazapine 30 mg was safe and well-tolerated in people receiving a clinically relevant intravenous methamphetamine challenge, supporting further development of this medication for the treatment of methamphetamine use disorder.
Authors
- John E. Walker (ORCID: https://orcid.org/0000-0001-7929-2162)
- Glenn‐Milo Santos (ORCID: https://orcid.org/0000-0003-1009-5317)
- Annie Fraser
- Lizette Sturgeon
- Finn T. Black
- J.C. Clark
- Phillip O. Coffin
- Marta Kochanska
- Vanessa M. McMahan
- Steve Shoptaw
Institutions
- Harvard University (US)
- University of California, Los Angeles (US)
- Unity Health System (US)
- San Francisco Department of Public Health (US)
- Harvard Pilgrim Health Care (US)
Publication Details
- Journal
- Journal of Clinical Psychopharmacology
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1097/jcp.0000000000002148
- Primary Topic
- Forensic Toxicology and Drug Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00